News
20/02/2019 - Agilent Technologies Inc. (NYSE: A) today announced that Professor Diether Lambrechts from the VIB-KU Leuven Center for Cancer Biology has received an Agilent Thought Leader Award in support of his research in cancer genomics.
24/11/2018 - Biocartis launched a fast, accurate msi assay on its idylla™ platform, offering the Potential to predict effective cancer treatment options.
10/10/2018 - The study, led by researchers at RCSI and the VIB-KU Leuven Center for Cancer Biology in Belgium, is a further important step in the global effort to move towards a more personalised treatment approach for colorectal cancer patients
17/07/2018 - Idylla™ MSI Assay further strengthens Biocartis’ test menu and offers opportunities to enter the immuno-oncology testing market
09/07/2018 - Researchers from VIB, Leuven University and University Hospital Leuven studied thousands of healthy and cancerous lung cells to create the first comprehensive atlas of lung tumor cells.
23/10/2017 - Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.
27/07/2017 - With their world-leading strengths in molecular research and biotechnology, various VIB labs are paving the way for novel diagnostic tools that will reduce disease burden and save lives by making disease diagnosis better, faster and more flexible.
24/04/2017 - Researchers at the Jules Bordet Institute, ULB, VIB and KU Leuven published a study offering a better understanding of the progression of breast cancer. The conclusions could have an impact on care for patients suffering from a metastatic breast cancer
29/10/2016 - A group of researchers lead by Diether Lambrechts (VIB-KU Leuven) explored the mechanisms that cause increased levels of methylation in tumor genes — information that is vital to the adaptation of therapies to fight different types of tumors.
17/08/2016 - The lack of oxygen in tumor cells changes the cells’ gene expression, thereby contributing to the growth of cancer. This is the main conclusion of a research project led by professor Diether Lambrechts and Dr. Bernard Thienpont (VIB-KU Leuven).
13/07/2015 - “These results will be the foundation of many future studies on the genetic aberrations controlling cancer development” - Diether Lambrechts, VIB-KU Leuven
09/12/2013 - ERC-grants grants for three VIB scientists: boost for innovative research
01/10/2010 - VIB has licensed the RTG v2 Software from Real Time Genomics, for variant detection with Complete Genomics data.
19/09/2010 - Diether Lambrechts identified – in collaboration with several international teams – susceptibility loci for different gynecological cancers. Their findings resulted in three Nature Genetics papers.